What Is Regenerative Medicine?
Regenerative medicine encompasses treatments that work with the body's own biology to repair damaged tissue, stimulate healing, and restore function โ rather than simply reducing symptoms or providing temporary pain relief. In the context of musculoskeletal pain management, this primarily means platelet-rich plasma (PRP) therapy and related biologic injection treatments that deliver concentrated growth factors directly to injured or degenerated tissue.
The appeal of regenerative medicine is its mechanism: instead of suppressing inflammation (corticosteroids) or masking pain signals (analgesics), regenerative treatments actively signal local cells to proliferate, migrate to the injury site, and synthesize new collagen and extracellular matrix โ the actual biological process of healing, amplified by the concentration of growth factors delivered. This distinction is particularly important for conditions involving chronic tendon degeneration, early-to-moderate joint arthritis, and ligamentous injuries where the normal healing response has failed to restore tissue integrity.
Regenerative Treatments Offered
Platelet-Rich Plasma (PRP) Therapy
PRP is our primary regenerative treatment. A small sample of your blood is drawn, then centrifuged to concentrate the platelet layer โ achieving 3โ8 times the baseline platelet concentration. Activated platelets release hundreds of growth factors from their alpha granules: platelet-derived growth factor (PDGF), transforming growth factor-beta (TGF-ฮฒ), vascular endothelial growth factor (VEGF), insulin-like growth factor (IGF-1), fibroblast growth factor (FGF), and more. When this concentrated solution is injected precisely into damaged tissue under ultrasound or fluoroscopic guidance, these growth factors initiate and amplify the healing cascade.
Dr. Qureshi tailors the PRP preparation to the target tissue and indication. Leukocyte-rich PRP is used for tendon and ligament injuries where an enhanced immune response supports healing. Leukocyte-poor PRP is preferred for intra-articular injections where white blood cell enzymes may irritate cartilage. This level of preparation nuance reflects current evidence-based practice.
Prolotherapy
Prolotherapy (proliferative therapy) involves injection of a mildly irritant solution โ typically dextrose (sugar water) at 12.5โ25% concentration โ into ligamentous and tendinous attachment sites to trigger a local inflammatory and regenerative response. It has a longer clinical history than PRP and strong evidence for specific conditions including sacroiliac joint ligamentous laxity, lateral epicondylitis, and Achilles tendinopathy. Prolotherapy is sometimes used in combination with PRP for enhanced effect.
Conditions Treated with Regenerative Medicine
- Knee osteoarthritis โ multiple randomized trials show PRP produces longer-lasting relief (6โ12+ months) with potential disease-modifying effects on cartilage compared to corticosteroid and hyaluronic acid
- Hip and shoulder osteoarthritis โ growing evidence for intra-articular PRP as an alternative to corticosteroid for longer-term management
- Rotator cuff tendinopathy and partial tears โ among the strongest evidence bases for PRP; superior outcomes to corticosteroid at 6โ12 months in multiple comparative studies
- Lateral epicondylitis (tennis elbow) โ one of the original and best-studied PRP indications; 2โ3 injection series produces superior long-term outcomes compared to corticosteroid
- Patellar and Achilles tendinopathy โ strong evidence for PRP, particularly in chronic cases failing conservative treatment
- Plantar fasciitis โ ultrasound-guided PRP produces significant improvement in chronic cases unresponsive to conservative care
- Sacroiliac joint ligamentous laxity โ prolotherapy and PRP for SI joint instability-related pain
- Muscle tears (Grade II) โ PRP accelerates biological repair in acute partial muscle tears
Read our detailed guide on PRP therapy for joint pain to learn how platelet-rich plasma promotes healing in arthritic joints and injured tendons.
The PRP Procedure
The entire process takes approximately 45โ60 minutes. Blood is drawn from your arm, centrifuged to concentrate the platelets, and the PRP layer is extracted under sterile conditions. Dr. Qureshi uses ultrasound or fluoroscopic guidance to deliver the PRP precisely into the damaged structure. You will experience a pressure sensation and often a temporary pain flare over the first 2โ5 days as the inflammatory healing cascade is initiated โ this is normal and expected.
What to Expect: Timeline and Results
PRP works through biological healing โ a slower, more durable process than steroid injection. Most patients notice the beginning of improvement at 4โ6 weeks, with continued benefit developing over 3โ6 months as new tissue matures and remodels. A series of 2โ3 injections spaced 4โ6 weeks apart is standard for most indications. Long-term results at 12โ24 months consistently show better outcomes than corticosteroid in high-quality comparative studies, particularly for knee OA and tendinopathies.